- 全部删除
- 您的购物车当前为空
Tegafur (FT 207) 是一种前药,在肝脏中被细胞色素 P-450 酶逐渐转化为氟尿嘧啶。它是抗代谢物氟尿嘧啶的同源物,具有抗肿瘤活性。
为众多的药物研发团队赋能,
让新药发现更简单!
Tegafur (FT 207) 是一种前药,在肝脏中被细胞色素 P-450 酶逐渐转化为氟尿嘧啶。它是抗代谢物氟尿嘧啶的同源物,具有抗肿瘤活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥ 148 | In stock | |
25 mg | ¥ 218 | In stock | |
50 mg | ¥ 297 | In stock | |
100 mg | ¥ 432 | In stock | |
500 mg | ¥ 835 | In stock | |
1 g | ¥ 1,220 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 195 | In stock |
Tegafur 相关产品
产品描述 | Tegafur (FT 207) is a congener of the antimetabolite fluorouracil with antineoplastic activity. Tegafur is a prodrug that is gradually converted to fluorouracil in the liver by the cytochrome P-450 enzyme. |
别名 | 替加氟, NSC 148958, FT-207, FT 207, Fluorafur |
分子量 | 200.17 |
分子式 | C8H9FN2O3 |
CAS No. | 17902-23-7 |
Smiles | O=C1N(C=C(F)C(=O)N1)C2CCCO2 |
密度 | 1.3222 g/cm3 (Estimated) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (249.79 mM), Sonication is recommended. ![]() Ethanol: 7 mg/mL (34.97 mM), Sonication is recommended. H2O: 8 mg/mL (39.97 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
Ethanol/H2O/DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容